$SSII
SS Innovations International, Inc. Stock $ssii

$ssii Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000121390024097890 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue			$1.363M
YoY Change
Cost Of Revenue		$2.106M	$1.545M
YoY Change		65.84%	389.32%
Gross Profit		$1.303M	-$181.7K
YoY Change		714.97%	-42.44%
Gross Profit Margin			-13.33%
Selling, General & Admin		$1.735M	$15.27M
YoY Change		36.08%	1581.57%
% of Gross Profit		133.19%
Research & Development		$1.300M	$576.2K
YoY Change		343.64%	689.71%
% of Gross Profit		99.81%
Depreciation & Amortization			-$64.60K
YoY Change			-2933.33%
% of Gross Profit
Operating Expenses		$7.239M	$15.85M
YoY Change		239.48%	1515.25%
Operating Profit		-$5.936M	-$16.03M
YoY Change		200.95%	1136.04%
Interest Expense			-$208.3K
YoY Change			357.97%
% of Operating Profit
Other Income/Expense, Net		-$183.3K	$120.0K
YoY Change		1497.07%	-29.4%
Pretax Income			-$16.12M
YoY Change			1274.82%
Income Tax
% Of Pretax Income
Net Earnings		-$6.119M	-$16.12M
YoY Change		208.45%	1274.82%
Net Earnings / Revenue			-1182.44%
Basic Earnings Per Share		-$0.04
Diluted Earnings Per Share		-$0.04	-$0.10
COMMON SHARES
Basic Shares Outstanding	170.9M shares	170.7M shares	169.1M shares
Diluted Shares Outstanding		170.8M shares

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.022M
YoY Change		49.65%
Cash & Equivalents	$220.4K	$2.022M
Short-Term Investments
Other Short-Term Assets	$1.311M	$8.386M
YoY Change	-81.41%	96511.75%
Inventory	$9.190M	$6.327M
Prepaid Expenses
Receivables	$5.103M	$1.647M
Other Receivables		$0.00
Total Short-Term Assets	$26.66M	$18.38M
YoY Change	37.95%	321.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.078M	$790.2K
YoY Change	214.07%	6831.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.778K	$0.00
YoY Change
Total Long-Term Assets	$11.15M	$7.096M
YoY Change	135.64%	62154.46%
TOTAL ASSETS
Total Short-Term Assets	$26.66M	$18.38M
Total Long-Term Assets	$11.15M	$7.096M
Total Assets	$37.81M	$25.48M
YoY Change	57.16%	482.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.854M	$900.9K
YoY Change	954.64%
Accrued Expenses		$2.330M
YoY Change		40783.51%
Deferred Revenue	$982.1K	$156.3K
YoY Change
Short-Term Debt		$6.019M
YoY Change		50.47%
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$18.94M	$9.271M
YoY Change	128.31%	128.84%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$1.910M
YoY Change
Total Long-Term Liabilities	$4.979M	$1.910M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.94M	$9.271M
Total Long-Term Liabilities	$4.979M	$1.910M
Total Liabilities	$23.92M	$11.18M
YoY Change	188.32%	175.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$41.90M	-$35.33M
YoY Change	98.72%	230.46%
Common Stock	$17.09K	$17.07K
YoY Change	-99.95%	216.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.89M	$14.30M
YoY Change
Total Liabilities & Shareholders Equity	$37.81M	$25.48M
YoY Change	57.16%	482.85%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$6.119M	-$16.12M
YoY Change	208.45%	1274.82%
Depreciation, Depletion And Amortization		-$64.60K
YoY Change		-2933.33%
Cash From Operating Activities		$258.3K
YoY Change		-122.81%
INVESTING ACTIVITIES
Capital Expenditures		$1.886M
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$4.533M
YoY Change		-338.6%
Cash From Investing Activities		$2.647M
YoY Change		-239.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-7.288M
YoY Change		-288.35%
NET CHANGE
Cash From Operating Activities		258.3K
Cash From Investing Activities		2.647M
Cash From Financing Activities		-7.288M
Net Change In Cash		-4.382M
YoY Change		-623.4%
FREE CASH FLOW
Cash From Operating Activities		$258.3K
Capital Expenditures		$1.886M
Free Cash Flow		-$1.628M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56608
	dei	Entity Registrant Name EntityRegistrantName	SS INNOVATIONS INTERNATIONAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3478854
	dei	Entity Address Address Line1 EntityAddressAddressLine1	405, 3rd Floor
	dei	Entity Address Address Line2 EntityAddressAddressLine2	iLabs Info Technology Centre
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Udyog Vihar, Phase III
	dei	Entity Address City Or Town EntityAddressCityOrTown	Gurugram, Haryana
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	122016
	dei	Entity Address Country EntityAddressCountry	IN
	dei	City Area Code CityAreaCode	+91
	dei	Local Phone Number LocalPhoneNumber	73375 53469
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	170864381	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220364	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2022276	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	5596681	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5029650	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5103449	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1901244	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	9190414	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6327256	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5392375	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3890017	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	26663932	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	20738002	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2077799	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	706405	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2801443	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2657554	usd
CY2024Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2382830	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2365013	usd
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	325642	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	35919	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	3560328	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	4322444	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	11148042	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10087335	usd
CY2024Q3	us-gaap	Assets Assets	37811974	usd
CY2023Q4	us-gaap	Assets Assets	30825337	usd
CY2024Q3	us-gaap	Bank Overdrafts BankOverdrafts	7088307	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	4950000	usd
CY2024Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	510189	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	510189	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	448415	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	396784	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1854133	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	901550	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	982064	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	156330	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3108167	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	489939	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	18941275	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8473718	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2480401	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2351113	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2464380	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	939150	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	33933	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	33933	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4978714	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3324196	usd
CY2024Q3	us-gaap	Liabilities Liabilities	23919989	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11797914	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170864381	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	170864381	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170710684	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	170710684	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	17087	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17072	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-319491	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-195499	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55195553	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	48507938	usd
CY2024Q3	ssii	Capital Reserves CapitalReserves	899917	usd
CY2023Q4	ssii	Capital Reserves CapitalReserves	899917	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41901082	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30202006	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	13891985	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	19027423	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37811974	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30825337	usd
	us-gaap	Cost Of Revenue CostOfRevenue	9605878	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4114825	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	2106029	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	1763478	usd
	us-gaap	Gross Profit GrossProfit	5419839	usd
	us-gaap	Gross Profit GrossProfit	751462	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1302677	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	16124	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1726359	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	781817	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1300241	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	293086	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6586381	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3337465	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1035861	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	110663	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	865942	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	39746	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7418541	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3293479	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1735098	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	453114	usd
	us-gaap	Operating Expenses OperatingExpenses	16767142	usd
	us-gaap	Operating Expenses OperatingExpenses	4185959	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	7238746	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	785946	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11347303	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3434497	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5936069	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-769822	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	892859	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	756537	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	493855	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	756537	usd
	us-gaap	Interest Income Other InterestIncomeOther	541086	usd
	us-gaap	Interest Income Other InterestIncomeOther	130228	usd
CY2024Q3	us-gaap	Interest Income Other InterestIncomeOther	310544	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	304019	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-351773	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-626309	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-183312	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-452518	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11699076	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4060806	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6119381	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1222340	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11699076	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4060806	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6119381	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1222340	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	170752346	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170752346	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115025577	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	115025577	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	170780324	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170780324	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146681176	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146681176	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	19027423	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2185195	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	101250	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2647861	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18666007	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2177045	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-2931834	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	17911217	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2224141	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-123992	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-6119381	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	13891985	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2770434	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2004320	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4774754	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6137906	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4464437	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	742271	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1850423	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4719437	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	16980000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-148453	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1222340	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	20378644	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11699076	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4060806	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	179171	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	138537	usd
	ssii	Shares Issued Against Services SharesIssuedAgainstServices	101249	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	266284	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103598	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	554328	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	37782	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6586381	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2863158	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3358101	usd
	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	289723	usd
	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	35908	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-762116	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	142224	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-406910	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	759709	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-675013	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2439056	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	52869	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2350964	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	700970	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3202205	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3824185	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	952583	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	482153	usd
	us-gaap	Increase Decrease In Long Term Receivables Current IncreaseDecreaseInLongTermReceivablesCurrent	120880	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1502358	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	668055	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	517298	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5474776	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12128972	usd
	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	-17817	usd
	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	886263	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1637678	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	257016	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1655495	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	629247	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	1069381	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	2993894	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4950000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	19980000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	20047	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	50000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6019381	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23043941	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1110890	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11544216	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-123991	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-212021	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7051926	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	274625	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5817045	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11606816	usd
	us-gaap	Stock Issued1 StockIssued1	101249	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2015-02-04
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one for ten
	ssii	Working Capital Deficit WorkingCapitalDeficit	7722657	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41901082	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11699076	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6119381	usd
	ssii	Percentage Of Total Procedures PercentageOfTotalProcedures	0.70	pure
CY2024Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	4950000	usd
CY2024Q3	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q3	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
	ssii	Accrued Interest Percentage AccruedInterestPercentage	0.07	pure
CY2024Q2	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2000000	usd
CY2024Q3	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	0.5	usd
CY2024Q3	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses. The Company regularly evaluates estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates made by management. Significant estimates included deferred revenue, costs incurred related to deferred revenue, stock-based compensation, leases, the useful lives of property and equipment</span></p>
	ssii	Closing Rate Of Forigen Currency Transaction ClosingRateOfForigenCurrencyTransaction	INR 83.71 to one US$
	ssii	Average Rate Of Foriegn Currency Transaction AverageRateOfForiegnCurrencyTransaction	83.38 INR to one US$
CY2024Q3	us-gaap	Inventory Net InventoryNet	9190414	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Concentration of Credit Risk</span></span><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash. The Company maintains its principal cash balance in United States financial institutions, where deposits are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company also maintains cash balances maintained with banks in India, where balances are insured by Deposit Insurance and Credit Guarantee Corporation of India (DICGC) to the extent of approximately $6,100 per account and in the Bahamas, where deposits are insured by the Deposit Insurance Corporation Bahamas up to B$50,000 (equivalent to $50,000) per account. As of September 30, 2024, the Company had <span style="-sec-ix-hidden: hidden-fact-45">none</span> of its deposits in excess of overall insurance coverage limits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	6100	usd
CY2024Q3	us-gaap	Time Deposits TimeDeposits	50000	bsd
CY2024Q3	us-gaap	Time Deposits TimeDeposits	50000	usd
	ssii	Percentage Of Restricted Shares PercentageOfRestrictedShares	0.20	pure
	ssii	Percentage Of Long Lived Assets PercentageOfLongLivedAssets	1	pure
CY2024Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	456785	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	175978	usd
CY2024Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	216728	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	175282	usd
CY2024Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	274270	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	282781	usd
CY2024Q3	ssii	Motor Vehicles Gross MotorVehiclesGross	244032	usd
CY2023Q4	ssii	Motor Vehicles Gross MotorVehiclesGross	183577	usd
CY2024Q3	ssii	Research And Develepment Equipment Gross ResearchAndDevelepmentEquipmentGross	141272	usd
CY2023Q4	ssii	Research And Develepment Equipment Gross ResearchAndDevelepmentEquipmentGross	119809	usd
CY2024Q3	ssii	Server Networking Gross ServerNetworkingGross	36008	usd
CY2023Q4	ssii	Server Networking Gross ServerNetworkingGross	21928	usd
CY2024Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	320247	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	154651	usd
CY2024Q3	ssii	Pay Per Use Systems Gross PayPerUseSystemsGross	1153482	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2842824	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1114006	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	765025	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	407601	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2077799	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	706405	usd
	us-gaap	Depreciation Depreciation	274939	usd
	us-gaap	Depreciation Depreciation	110663	usd
CY2024Q3	us-gaap	General Partners Contributed Capital GeneralPartnersContributedCapital	3000000	usd
	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2023-04-07
CY2024Q3	us-gaap	Investments Investments	3000000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5103449	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1901244	usd
CY2024Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2382830	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2365013	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	7486279	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	4266257	usd
CY2024Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2382830	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220364	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2022276	usd
CY2024Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	5596681	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5029650	usd
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	325642	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	35919	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6142687	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7087845	usd
CY2024Q3	ssii	Receivables From Statutory Authorities Current ReceivablesFromStatutoryAuthoritiesCurrent	2859376	usd
CY2023Q4	ssii	Receivables From Statutory Authorities Current ReceivablesFromStatutoryAuthoritiesCurrent	1904859	usd
CY2024Q3	ssii	Prepaid Expense Stock Compensation Current PrepaidExpenseStockCompensationCurrent	1074991	usd
CY2023Q4	ssii	Prepaid Expense Stock Compensation Current PrepaidExpenseStockCompensationCurrent	1066991	usd
CY2024Q3	ssii	Security Deposit Current SecurityDepositCurrent	147364	usd
CY2023Q4	ssii	Security Deposit Current SecurityDepositCurrent	299540	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1310644	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	618626	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5392375	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3890017	usd
CY2024Q3	ssii	Prepaid Expense Stock Compensation Non Current PrepaidExpenseStockCompensationNonCurrent	3321209	usd
CY2023Q4	ssii	Prepaid Expense Stock Compensation Non Current PrepaidExpenseStockCompensationNonCurrent	4090131	usd
CY2024Q3	ssii	Security Deposits Noncurrent SecurityDepositsNoncurrent	232341	usd
CY2023Q4	ssii	Security Deposits Noncurrent SecurityDepositsNoncurrent	225488	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6778	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6825	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	3560328	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	4322444	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8952703	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8212462	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1854133	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	901550	usd
CY2024Q3	ssii	Payable To Statutory Authorities Current PayableToStatutoryAuthoritiesCurrent	59430	usd
CY2023Q4	ssii	Payable To Statutory Authorities Current PayableToStatutoryAuthoritiesCurrent	35149	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	318206	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	310789	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2730531	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	144002	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3108167	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	489939	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	33933	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	33933	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	33933	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	33933	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4996233	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1425422	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.45
CY2024Q3	us-gaap	Bank Overdrafts BankOverdrafts	7088307	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2024Q3	us-gaap	Deposits Deposits	5529676	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1095480	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	43917	usd
	ssii	Contract With Customer Liability Current Additions ContractWithCustomerLiabilityCurrentAdditions	2441449	usd
	ssii	Contract With Customer Liability Current Additions ContractWithCustomerLiabilityCurrentAdditions	622408	usd
	ssii	Contract With Customer Liability Current Net Changes In Liability For Preexisting Contracts ContractWithCustomerLiabilityCurrentNetChangesInLiabilityForPreexistingContracts	3536929	usd
	ssii	Contract With Customer Liability Current Net Changes In Liability For Preexisting Contracts ContractWithCustomerLiabilityCurrentNetChangesInLiabilityForPreexistingContracts	666325	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	90485	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3446445	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	666325	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3446445	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	666325	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3350221	shares
CY2024Q3	ssii	Options To The Extent Vested Expire Term OptionsToTheExtentVestedExpireTerm	P5Y
CY2024Q1	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.45
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2801443	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2657554	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	448415	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	396784	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2480401	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2351113	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2928816	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2747897	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4153107	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1224291	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2928816	usd
CY2024Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	9000	shares
CY2024Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.09	pure
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q2	ssii	Stock Issued During Period Value Recapitalization StockIssuedDuringPeriodValueRecapitalization		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
	us-gaap	Increase Decrease In Long Term Receivables Current IncreaseDecreaseInLongTermReceivablesCurrent		usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables		usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Payments For Deposits PaymentsForDeposits		usd
CY2024Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross		usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross		usd
CY2023Q4	ssii	Pay Per Use Systems Gross PayPerUseSystemsGross		usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001676163

Files In Submission

Name	View Source	Status
0001213900-24-097890-index-headers.html	Edgar Link	pending
0001213900-24-097890-index.html	Edgar Link	pending
0001213900-24-097890.txt	Edgar Link	pending
0001213900-24-097890-xbrl.zip	Edgar Link	pending
ea0220689-10q_ssinnova.htm	Edgar Link	pending
ea022068901ex31-1_ssinnova.htm	Edgar Link	pending
ea022068901ex31-2_ssinnova.htm	Edgar Link	pending
ea022068901ex32-1_ssinnova.htm	Edgar Link	pending
ea022068901ex32-2_ssinnova.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0220689-10q_ssinnova_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssii-20240930.xsd	Edgar Link	pending
ssii-20240930_cal.xml	Edgar Link	unprocessable
ssii-20240930_def.xml	Edgar Link	unprocessable
ssii-20240930_lab.xml	Edgar Link	unprocessable
ssii-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSII
SS Innovations International, Inc. Stock $ssii

2024 Q4 Form 10-Q Financial Statement

#000121390024097890 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII SS Innovations International, Inc. Stock $ssii

2024 Q4 Form 10-Q Financial Statement

#000121390024097890 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII
SS Innovations International, Inc. Stock $ssii